arrow
D

Denis M. Collins

school of bio technology
H指数:21
被引数:1,655

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combining orally available selective estrogen receptor degraders with pan-HER tyrosine kinase inhibitor neratinib in pre-clinical models of HER2+/ER+ breast cancer

将口服可用的选择性雌激素受体降解剂与泛HER酪氨酸激酶抑制剂neratinib在HER2+/ER+乳腺癌的预临床模型中联合应用

2026-08-050
OA
Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients

染色体着丝粒拷贝数扩增与HER2阳性转移性乳腺癌患者中的非凡反应相关

2025-12-200
OAAI
Five year follow up of a randomized phase II comparison of neo-adjuvant docetaxel, carboplatin, trastuzumab with or without lapatinib in HER-2 positive breast cancer
2023-03-010
PRE